• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Potential Herb-Drug Interactions for Commonly
Potential Herb-Drug Interactions for Commonly

... A recommended action is suggested on a risk assessment of the information in the Basis of Concern. In these examples: It is recommended that St John’s wort is contraindicated in patients taking cancer chemotherapeutic drugs. In the case of gliclazide, because the trial found little effect on a c ...
IOSR Journal of Environmental Science, Toxicology and Food Technology (IOSR-JESTFT)
IOSR Journal of Environmental Science, Toxicology and Food Technology (IOSR-JESTFT)

... half-life of 2-4h. It is highly lipid soluble and has a distribution half-life of approximately 7-11 min. Ketamine is metabolized to at least two compounds: first by N-demethylation, to norketamine, which has 1/3-1/2 of the potency of ketamine. Norketamine is further dehydrogenated to produce dehydr ...
FORMULATION AND EVALUATION OF GASTRO RETENTIVE IN
FORMULATION AND EVALUATION OF GASTRO RETENTIVE IN

... : Mean percent dissolved at each time point for the reference and test dissolution profiles The two dissolution profiles are considered similar or closeness between two ...
OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018 Brochure
OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018 Brochure

... young children there is a need for medications which are safe and effective in the pediatric population. The ASD market is expected to grow remain relatively flat between 2012 and 2018, which is predominantly due to various drug patent expiration, and the introduction of novel therapies in the US an ...
Week 8 Review Pharmacology
Week 8 Review Pharmacology

... Major SE of sympatholytic (betas) and direct-acting vasodilators is _________.sodium/water retention [metoprolol (Lopressor), methyldopa(Aldomet), nitroprusside (Nipride)] Pt should wear medicAlert bracelet with _______because they block the compensatory effects of the body to the shock state. Gluca ...
Prescrire`s Response (112)
Prescrire`s Response (112)

... However, even with the INN system there is a residual risk of confusion, partly owing to the sheer number of INNs now in circulation. A report from the Council of Europe, which recommends the use of INNs, calls for active participation in the public consultations on proposed INNs organised by the Wo ...
Chapter 5 Drug Labels and Package Inserts
Chapter 5 Drug Labels and Package Inserts

... Storage at the wrong temperature or exposure to light can trigger a chemical reaction and make the drug unusable. ...
Chapter 5 Drug Labels and Package Inserts
Chapter 5 Drug Labels and Package Inserts

... Storage at the wrong temperature or exposure to light can trigger a chemical reaction and make the drug unusable. ...
Ravimid laste jaoks
Ravimid laste jaoks

... 1. Sponsor submits an IND for an adult indication 2. Division must decide if pediatric studies are needed and if they can be deferred or if pediatric studies can be waived. 3. If studies are required the time table and general outline are decided before an action is taken on the application. 4. Ther ...
Investigation of Drug Interaction Studies of Levocetirizne with HMG
Investigation of Drug Interaction Studies of Levocetirizne with HMG

... The combination of HMG-CoA reductase inhibitors with certain drugs that are CYP3A4 inhibitors or substrates increases the risk of myopathy, presumably by inhibiting the metabolism of the HMGCoA reductase inhibitors and increasing its blood concentration. These drugs include cyclosporine [16], erythr ...
The Řie-Tozer Model of Drug D
The Řie-Tozer Model of Drug D

... and Manufacturers of America (PhRMA) group, the Øie-Tozer model was found to be superior to many other approaches for the prediction of human volume of distribution at steady state (Vss) [22]. However, application of the Øie-Tozer model can be inappropriate for certain drugs or drug classes due to t ...
Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis
Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

... The World Health Organization (WHO) estimates that 2.5% of all TB patients and 3% of all new cases are infected with MDR-TB [7, 8]; an estimated 650 000 prevalent cases of MDR-TB occurred globally in 2010 [9]. The proportions of new TB cases with MDR-TB in Eastern European countries are at alarming ...
Preventing and Curing Infectious Diseases: Carbohydrate
Preventing and Curing Infectious Diseases: Carbohydrate

... Infectious diseases kill many millions of people each year, not just in developing countries nut increasingly in industrialized nations as well. We are in danger of entering a “post-antibiotic” era as the drugs against many infectious diseases are becoming inactive due to the emergence of resistance ...
Quantitative Rationalization of Gemfibrozil Drug Interactions
Quantitative Rationalization of Gemfibrozil Drug Interactions

... involving inhibition of multiple transporters and cytochrome P450 2C8 (CYP2C8) by parent and a circulating metabolite, gemfibrozil 1-O-b-glucuronide (Gem-Glu). Cerivastatin was withdrawn from the worldwide market in 2001 because of a higher incidence of fatal rhabdomyolysis linked to increased expos ...
Do You Know... Anabolic Steroids
Do You Know... Anabolic Steroids

... testosterone. The muscle-building (anabolic) and masculinizing (androgenic) effects of these drugs make them appealing to athletes and bodybuilders. The primary use of anabolic steroids is to promote growth in farm animals. In humans they are sometimes prescribed to treat delayed puberty, some types ...
Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal,
Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal,

... totalled approximately $1.3 billion in the U.S. while the total market grew to more than $1.7 billion, driven by a 11 percent increase in prescriptions. In 2014, Bunavail buccal film has received US approval which has similar bioavailability of suboxone with half of the dose of buprenorphine. Other ...
DESIGN AND INVITRO CHARACTERIZATION OF FLOATING PULSATILE MICROSPHERES OF  ACECLOFENAC FOR RHEUMATOID ARTHRITIS 
DESIGN AND INVITRO CHARACTERIZATION OF FLOATING PULSATILE MICROSPHERES OF  ACECLOFENAC FOR RHEUMATOID ARTHRITIS 

... reduced dose, improved patient compliance and increased gastric  residence of the dosage form  2‐5. Additionally, multiple unit dosage  forms  provides  many  relative  advantages  over  single  unit  dosage  forms  such  as  predictable  GI  transit  time,  maximum  drug  absorption with reduced in ...
Medicaid Approved Formulary Drug List
Medicaid Approved Formulary Drug List

... The Anthem Blue Cross (Anthem) Medicaid Managed Care-Approved Formulary Drug List is a list of drugs covered under your benefit. These are commonly prescribed Food and Drug Administration (FDA)-approved drugs chosen by Anthem for their value and effectiveness. Select drugs may require prior authoriz ...
Inspire Complaint
Inspire Complaint

... AzaSite for the treatment of blepharitis, a type of lid margin disease characterized by an inflammation of the eyelids. Blepharitis can occur on the outside front of the eyelid where the eyelashes attach, as well as on the inner eyelid. The standard of care for the treatment of blepharitis is good ...
FORMULATION, EVALUATION AND OPTIMIZATION OF SOLID DISPERSION OF GLIPIZIDE
FORMULATION, EVALUATION AND OPTIMIZATION OF SOLID DISPERSION OF GLIPIZIDE

... Glipizide (GZ) can acutely lower the blood glucose level in humans by stimulating the release of insulin from the pancreas and is typically prescribed to treat non insulin dependent diabetes mellitus12. The drug is insoluble in water, and its dissolution is considered to be a rate-determining step ( ...
Drug Discovery and Creation
Drug Discovery and Creation

... • All drugs must be thoroughly tested • Tested by the company before marketing according to FDA guidelines ...
Drugs of Abuse - Americans for Safe Access
Drugs of Abuse - Americans for Safe Access

... (2) There is significant diversion of the drug or other substance from legitimate drug channels. (3) Individuals are taking the drug or other substance on their own initiative rather than on the basis of medical advice from a practitioner. (4) The drug is a new drug so related in its action to a dru ...
Synergistic interactions of SQ109, a new
Synergistic interactions of SQ109, a new

... may exist between the two drugs, suggesting a weak enhancement between them. If x/y values are greater than 2, it suggests antagonistic interactions between the two drugs. The window between x/y greater than 1 and less than 2 is the transition area from no effect to antagonistic. By applying simple ...
Association between KEGG Biological Pathways and Adverse Drug
Association between KEGG Biological Pathways and Adverse Drug

... Abstract—In South Africa, the proportion of patients admitted to hospitals with Adverse Drug Reactions (ADRs) range between 2-21.4% and between 1.7 to 25.1% of hospital in-patients are reported to have developed ADRs in hospitals. Drugs are therefore responsible for significant mobility and mortalit ...
Curr.Med. Chem._Martínez, A._2015 - digital
Curr.Med. Chem._Martínez, A._2015 - digital

... to molecules where an AChE inhibitor is linked to other active compounds and finally to compounds able to interact simultaneously with two targets involved in AD. The importance of the multitarget strategy in complex diseases as neurodegenartive ones, especially Alzheimer disease, will be here descr ...
< 1 ... 12 13 14 15 16 17 18 19 20 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report